Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol

EU orphan designation number: EU/3/11/896   
Active ingredient: Multilamellar microvesicle comprising phosphatidylcholine, sphingomyelin, phosphatidylethanolamine, phosphatidylserine, phospatidylinositol and cholesterol
Indication: Treatment of cystic fibrosis
Sponsor: Lamellar Biomedical Ltd
Sterling House, 20 Renfield Street, Glasgow G2 5AP, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
01/09/2011 Centralised Orphan - Designation EMA/OD/037/11 (2011)6281 of 30/08/2011